Additional Information
Market: ASX
Sector: Pharmaceuticals & Biotechnology
EPIC: STI
Latest Price: A$0.00  (0,00%)
52-week High: A$0.00
52-week Low: A$0.00
Market Cap: A$4.45M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Stirling Products
www.stirlingproducts.net

Stirling Products (ASX:STI) is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties.  Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.

The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.

Stirling operates through three main business units each managed by proven industry specialist managers:

- Pharmaceutical & Healthcare
- Research & Development
- Animal Products

Pdf

Stirling Products provides update on Canadian pharmaceutical plant

14th Jul 2010, 8:35 am

Stirling Products (ASX:STI) has provided an update on its Canadian pharmaceutical plant, it owns in Cape Breton, through which it will provide contract manufacturing services as well manufacture its own products.

The company has advised that its pharmaceutical plant re-validation of all plant, equipment and processes is ahead of schedule and application for inspection will be forwarded to Health Canada this week.

Following receipt of application, Health Canada then has 90 days within which to arrange an inspection following which the plant licensing is expected to issue and production can then commence.

The Company is hopeful that this inspection will be at the earlier end of the 90 period and will keep the market advised as soon as inspection is arranged.

The current fit-out and configuration of the plant provides for an annual capacity to manufacture and package over 550 million tablets, 5 million bottles and blend up to 1.5 million kg of product.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.